Eisai Co., Ltd. (OTCMKTS:ESALY – Get Free Report) passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $61.51 and traded as low as $61.00. Eisai shares last traded at $61.51, with a volume of 331,800 shares changing hands.
Eisai Stock Down 2.1%
The business’s fifty day simple moving average is $61.51 and its 200 day simple moving average is $61.51. The company has a current ratio of 2.20, a quick ratio of 1.77 and a debt-to-equity ratio of 0.10. The stock has a market cap of $17.64 billion, a price-to-earnings ratio of 70.70, a price-to-earnings-growth ratio of 2.46 and a beta of 0.31.
Eisai Company Profile
Eisai Co, Ltd. is a research-driven global pharmaceutical company headquartered in Tokyo, Japan. Founded in 1941 by Toyoji Naito, Eisai focuses on the discovery, development, manufacture and commercialization of prescription medicines and related healthcare products. The company emphasizes neuroscience and oncology as core therapeutic areas and invests in both small-molecule and biologic research to address unmet medical needs.
Among its well-known products, Eisai developed and markets Aricept (donepezil), a widely used treatment for the symptoms of Alzheimer’s disease, and LENVIMA (lenvatinib), an oncology therapy for several tumor types.
Recommended Stories
- Five stocks we like better than Eisai
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for Eisai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eisai and related companies with MarketBeat.com's FREE daily email newsletter.
